Abstract
The influence of haemoperfusion on blood-coagulation and cellular constituents of the blood was studied in three groups of patients. In four patients haemoperfusion was performed using a column containing acrylic-hydrogel coated activated charcoal (Haemocol), in five patients with a column containing uncoated XAD-4 nonionic polystyrene resin (Amberlite) and in five patients with a column containing cellulose coated activated charcoal (Gambro Adsorba 300 C). Perfusion was performed during 4 h with a flow of 300 ml/min. Before the start, 2 h after the start, at the end and 2 h after the end of the perfusion the haemoglobin concentration, haematocrit, leucocyte number, differential white cell count, thrombocyte number and heparin concentration were measured. Before the start and 2 h after the end prothrombin time, thrombin time, partial thromboplastin time, reptilase time, fibrinogen, prothrombin, factors V, VII, X, antithrombin III, bleeding time (Ivy), ethanol gelation test, fibrin split products and plasminogen were measured.
The following conclusions can be drawn: haemoperfusion per se causes haemodilution; polystyrene resin causes in some patients a temporary reduction of the leucocyte number during haemoperfusion; polystyrene resin causes a significant reduction of thrombocyte number compared to coated activated charcoal; polystyrene resin and to a lesser extent acrylic-hydrogel-coated activated charcoal causes in some patients a prolongation of bleeding time probably by inducing alteration of thrombocyte function caused by release; polystyrene resin and probably also acrylic-hydrogel-coated activated charcoal causes an increased fibrinolytic activity without signs of disseminated intravascular coagulation.
Similar content being viewed by others
References
Beurling-Harbury C, Galvan CA (1978) Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease. Blood 52: 13–23
Brookings CH, Ramsey JD (1975) Salicylate removal by charcoal haemoperfusion in experimental intoxications in dogs: an assessment of efficacy and safety. Arch Toxicol 34: 243–252
Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacobs HS (1977) Complement and leucocyte-mediated pulmonary dysfunction in haemodialysis. N Engl J Med 296: 769–774
Groot G, de, Maes RAA, Heijst ANP, van (1980) A toxicological evaluation of haemoperfusion using pharmacokinetic principles. In: Holmstedt B (ed) Mechanisms of toxicity and hazard evaluation. Elsevier/North Holland Biomedical Press, Amsterdam, pp 387–395
Hennemann H, Richter IE, Brunswig D, Rockel A, Kult J, Gattenlohner W, Heidland A (1977) Hämoperfusion — Pro und Kontra. Klin Wochenschr 55: 533–537
Kolthammer JC, Watson PA, Lang S, Fennimore J (1976) The safety assessment in the dog of a charcoal haemoperfusion column. Clin Sci Mol Med 51: 515–524
Marder VJ (1970) A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy. Thromb Diath Haemorrh 24: 230–239
Pall H, Kleinberger G, Kotzaurek R, Niesser H, Pichler M (1977) Gerinnungsstörungen im Rahmen der Hämoperfusion. Wien Klin Wochenschr 89: 347–350
Author information
Authors and Affiliations
Additional information
A part of the results of this study was presented at the IXth International Congress of the European Association of Poison Control Centers in Thessaloniki, Greece, 1980
Rights and permissions
About this article
Cite this article
Sangster, B., van Heijst, A.N.P. & Sixma, J.J. The influence of haemoperfusion on haemostasis and cellular constituents of the blood in the treatment of intoxications. Arch Toxicol 47, 269–278 (1981). https://doi.org/10.1007/BF00332393
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00332393